A Bioreactor Method to Generate High-titer, Genetically Stable, Clinical-isolate Human Cytomegalovirus.

about

A Bioreactor Method to Generate High-titer, Genetically Stable, Clinical-isolate Human Cytomegalovirus.

Item

http://www.wikidata.org/entity/Q46065213

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A Bioreactor Method to Generat ...... isolate Human Cytomegalovirus.

@en

A Bioreactor Method to Generat ...... isolate Human Cytomegalovirus.

@nl

type

Item

label

A Bioreactor Method to Generat ...... isolate Human Cytomegalovirus.

@en

A Bioreactor Method to Generat ...... isolate Human Cytomegalovirus.

@nl

prefLabel

A Bioreactor Method to Generat ...... isolate Human Cytomegalovirus.

@en

A Bioreactor Method to Generat ...... isolate Human Cytomegalovirus.

@nl

P1476

A Bioreactor Method to Generat ...... isolate Human Cytomegalovirus.

@en

P2093

Cynthia Bolovan-Fritts

http://www.w3.org/2001/XMLSchema#string

Jeff Sasaki

http://www.w3.org/2001/XMLSchema#string

Leor S Weinberger

http://www.w3.org/2001/XMLSchema#string

Luke I Rast

http://www.w3.org/2001/XMLSchema#string

Seung-Yong Jung

http://www.w3.org/2001/XMLSchema#string

Victoria R Saykally

http://www.w3.org/2001/XMLSchema#string

P2860

Simple and highly efficient BAC recombineering using galK selection

Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein.

Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains

Congenital cytomegalovirus mortality in the United States, 1990-2006.

Candidate cytomegalovirus strain for human vaccination.

The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics.

Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency.

An endogenous accelerator for viral gene expression confers a fitness advantage.

The "silent" global burden of congenital cytomegalovirus.

Desirability and feasibility of a vaccine against cytomegalovirus.

P31

scholarly article

P356

10.21769/BIOPROTOC.2589

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29226181

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

5718198

http://www.w3.org/2001/XMLSchema#string